Showing 11 - 20 of 35
Economic disparities between the regions of the European Union are of constant concern both for policy and economic research. In this paper we examine whether there are overlapping trends of regional development in the EU: overall convergence on the one hand and persistent or even increasing...
Persistent link: https://www.econbiz.de/10010260880
Economic disparities between the regions of the European Union are of constant concern both for policy and economic research. In this paper we examine whether there are overlapping trends of regional development in the EU: overall convergence on the one hand and persistent or even increasing...
Persistent link: https://www.econbiz.de/10003217220
The Risk Adjustment Reform Act of 2001 mandates that a health-status-based risk adjustment mechanism has to be implemented in Germanys̕ Statutory Health Insurance system by January 1, 2007. German parliament decided this as with the existing demographic risk adjustment model, that means there...
Persistent link: https://www.econbiz.de/10002513389
Economic disparities between the regions of the European Union are of constant concern both for policy and economic research. In this paper we examine whether there are overlapping trends of regional development in the EU: overall convergence on the one hand and persistent or even increasing...
Persistent link: https://www.econbiz.de/10003074580
Persistent link: https://www.econbiz.de/10001729161
Persistent link: https://www.econbiz.de/10001664653
Persistent link: https://www.econbiz.de/10001770613
Persistent link: https://www.econbiz.de/10012004893
Methods used by CEAs of oral non-disease-altering OA treatments have evolved in response to changing treatments with different safety profiles and efficacies as well as technical advances in the application of decision science to health care. </AbstractSection> Copyright Springer International Publishing...
Persistent link: https://www.econbiz.de/10011000760
The model estimated that duloxetine was potentially cost effective in the base-case population and more cost effective for subgroups over 65 years or at high risk of NSAID-related AEs. In sensitivity analysis, duloxetine dominated all strong opioids in nearly all scenarios. </AbstractSection> Copyright Springer...
Persistent link: https://www.econbiz.de/10011000776